WELLINGTON (Reuters) – New Zealand’s medicines regulator Medsafe has provisionally approved the use of the Pfizer/BioNTech coronavirus vaccine for 12- to 15-year-olds, Prime Minister Jacinda Ardern announced on Monday.
“After careful consideration of the most up-to-date scientific and medical data available, Medsafe has announced provisional approval for our young people to be given the Pfizer vaccine,” Ardern said in a statement.
There are around 265,000 children in the 12-15 age bracket in New Zealand, she said.
(Reporting by Praveen Menon; Editing by Muralikumar Anantharaman)
